Ermenistan - İngilizce - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - fluorouracil - concentrate for solution for infusion - 50mg/ml

Ermenistan - İngilizce - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - fluorouracil - concentrate for solution for infusion - 50mg/ml

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

accord healthcare limited, united kingdom - fluorouracil - solution for injection/infusion - 50 mg/ml

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

accord healthcare limited, united kingdom - fluorouracil - solution for injection/infusion - 50 mg/ml

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

accord healthcare limited, united kingdom - fluorouracil - solution for injection/infusion - 50 mg/ml

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

accord healthcare limited, united kingdom - fluorouracil - solution for injection/infusion - 50 mg/ml

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - phenytoin sodium 50 mg/ml - solution for injection - 50 mg/ml - active: phenytoin sodium 50 mg/ml excipient: ethanol hydrochloric acid propylene glycol sodium hydroxide water for injection - latest regulatory activity

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - phenytoin sodium 50 mg/ml - solution for injection - 50 mg/ml - active: phenytoin sodium 50 mg/ml excipient: ethanol propylene glycol sodium hydroxide water for injection

ABD - İngilizce - NLM (National Library of Medicine)

spear dermatology products inc - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 5 mg in 1 g - fluououracil cream 0.5% is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp. fluorouracil may cause fetal harm when administered to a pregnant woman. fluorouracil is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. no adequate and well-controlled studies have been conducted in pregnant women with either topical or parenteral forms of fluorouracil. one birth defect (ventricular septal defect) and cases of miscarriage have been reported when fluorouracil was applied to mucous membrane areas. multiple birth defects have been reported in the fetus of a patient treated with intravenous fluorouracil. animal reproduction studies have not been conducted with fluorouracil cream 0.5%. fluorouracil, the active ingredient, has been shown to be teratogenic in mice, rats, and hamsters when adm

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon, rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervcial particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.